Mobile Applications for Exercise Adherence and Hand Function in Chronic Stroke.
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Nov 18, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how mobile applications can help people who have had a stroke stay active and improve their hand function. After a stroke, many individuals struggle with using their arms and hands, which can make everyday activities difficult. Researchers are exploring whether using fun mobile video games as part of rehabilitation can motivate patients to exercise more regularly and enhance their dexterity.
To participate in this trial, individuals must be between 30 and 75 years old and have had a stroke at least six months ago but no more than two years ago. They should also be able to sit up without support and not have severe issues with movement or communication. Participants can expect to use mobile apps designed to track their progress and make exercises enjoyable. This study aims to find better ways to support stroke recovery and help patients regain their independence in daily tasks.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and female patients age 30 to 75 years were included.
- • Chronic stroke patients ranging from 6 months to 2 years (41).
- • Participants having a stroke severity score \> 6 on National Institute of Health Stroke Scale (NIHSS) (42).
- • Modified Ashworth scale score ≤ 3 of the affected upper extremity (44).
- • Montreal Cognitive Assessment (MoCA) score ≥ 26 (45).
- • Patients who are able to sit without support.
- • No contractures of the affected wrist and fingers.
- Exclusion Criteria:
- • Participants who show the symptoms of global or receptive aphasia.
- • Participants who have medical problems or co-morbidities that interdict their participation in the study (such as shoulder pain in the paretic limb).
- • Patients with severe apraxia, somatosensory problems.
- • Severe spasticity of the affected wrist and finger flexors.
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Binish Afzal, MS-NMPT
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported